Sanjiv Patel - 06 Jan 2026 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Signature
/s/ Soo-Yeun Lim, as attorney-in-fact
Issuer symbol
RLAY
Transactions as of
06 Jan 2026
Net transactions value
-$334,602
Form type
4
Filing time
07 Jan 2026, 16:15:03 UTC
Previous filing
04 Nov 2025
Next filing
15 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patel Sanjiv President and CEO, Director C/O RELAY THERAPEUTICS, INC., 60 HAMPSHIRE STREET, CAMBRIDGE /s/ Soo-Yeun Lim, as attorney-in-fact 07 Jan 2026 0001816210

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Award $2,972 +994 +0.14% $2.99 704,209 31 Dec 2025 Direct F1, F2, F3
transaction RLAY Common Stock Sale $337,574 -43,168 -6.1% $7.82 661,041 06 Jan 2026 Direct F4
holding RLAY Common Stock 199,548 06 Jan 2026 By The Patel Family Irrevocable Trust of 2019 F5
holding RLAY Common Stock 687,355 06 Jan 2026 By The SSP Irrevocable Trust of 2020 F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the Relay Therapeutics, Inc. 2020 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction.
F2 In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on July 1, 2025.
F3 Includes 136,854 shares underlying restricted stock units ("RSUs").
F4 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 136,854 shares of RSUs on January 5, 2026. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F5 These shares are held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F6 These shares were held in irrevocable trusts for the benefit of the reporting person's family members. An independent trustee is trustee of the trusts. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.